DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Insurance
Author Program NEWCreate Narrative
SLQT logo

SelectQuote, Inc. Stock Price

NYSE:SLQT Community·US$88.3m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 7 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

SLQT Share Price Performance

US$0.50
-1.58 (-75.96%)
​
US$2.31
Fair Value
US$0.50
-1.58 (-75.96%)
78.4% undervalued intrinsic discount
US$2.31
Fair Value
Price US$0.50
AnalystConsensusTarget US$2.31
AnalystLowTarget US$0.50
AnalystHighTarget US$5.00
Wed, 26 Aug 26
Fair ValueUS$2.31
Share Pricen/a

SLQT Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$2.31 78.4% undervalued intrinsic discount

Healthcare Services And Medicare Will Boost Future Momentum Amid Risks

0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value US$0.5 Fairly Valued intrinsic discount

Digital And Regulatory Challenges Will Squeeze Margins Yet Kindle Progress

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value US$5 90.0% undervalued intrinsic discount

Aging And Digital Trends Will Fuel Medicare Demand Amid Hurdles

1users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
SLQT logo
SelectQuote
Fairly Valued intrinsic discount
Updated

Digital And Regulatory Challenges Will Squeeze Margins Yet Kindle Progress

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 9 Sep
Read Narrative
SLQT logo
SelectQuote
78.4% undervalued intrinsic discount

Healthcare Services And Medicare Will Boost Future Momentum Amid Risks

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 26 Aug
Read Narrative
SLQT logo
SelectQuote
90.0% undervalued intrinsic discount

Aging And Digital Trends Will Fuel Medicare Demand Amid Hurdles

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 6 Jun
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystLowTarget
SLQT logo

SLQT: Softer Revenue Outlook And FY26 Guidance Will Shape Future P/E

Fair Value: US$0.5 Fairly Valued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
SLQT logo

SLQT: Improved Profitability And Reset Expectations Will Support Future Upside

Fair Value: US$2.31 78.4% undervalued intrinsic discount
4 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
SLQT logo

SLQT: Earnings Outlook And Margin Improvement Will Support Future Upside Potential

Fair Value: US$5 90.0% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Adequate balance sheet with slight risk.

4 Risks
1 Reward
View Full Analysis

SelectQuote, Inc. Key Details

US$1.6b

Revenue

US$1.0b

Cost of Revenue

US$575.6m

Gross Profit

US$587.2m

Other Expenses

-US$11.6m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
-0.066
35.56%
-0.72%
56.9%
View Full Analysis

About SLQT

Founded
1985
Employees
4039
CEO
Timothy Danker
WebsiteView website
www.selectquote.com

SelectQuote, Inc. operates a technology-enabled, direct-to-consumer distribution and engagement platform that sells insurance policies and healthcare services in the United States. The company operates through three segments: Senior, Healthcare Services, and Life. It offers medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance-related products, as well as engages in lead generation business; term life, final expense, and other ancillary products; non-commercial auto and home, property, and casualty insurance products. The company also provides SelectRx, a patient-centered pharmacy; Healthcare Select, which uses data from personal health risk and lifestyle assessment; SelectPatient Management (SPM), a platform that helps patients navigate their chronic conditions and manage them using a treatment plan; and individual automobile and homeowners’ insurance. SelectQuote, Inc. was founded in 1985 and is headquartered in Overland Park, Kansas.

Recent SLQT News & Updates

User avatar
Narrative Update • Sep 09

SLQT: Softer Revenue Outlook And FY26 Guidance Will Shape Future P/E

Analysts have reduced their price target on SelectQuote from $5 to $3, citing softer revenue expectations and lower projected fiscal 2027 revenue of about $1.4b and adjusted EBITDA of roughly $98.8m compared with prior estimates. What’s in the News for SelectQuote SelectQuote issued earnings guidance for fiscal 2026, with revenue expected in a range of $1.35 billion to $1.45 billion.
User avatar
Narrative Update • Aug 26

SLQT: Improved Profitability And Reset Expectations Will Support Future Upside

Analysts have trimmed their fair value estimate for SelectQuote, with the price target moving from about $3.06 to roughly $2.31. They cite softer revenue expectations into fiscal 2027, even as profitability metrics improved and future P/E assumptions reset to more conventional levels.

Recent updates

No updates

SelectQuote, Inc. Competitors

OSG logo

Octave Specialty Group

Symbol: NYSE:OSG
Market cap: US$218.0m
PKIN logo

Pekin Life Insurance

Symbol: OTCPK:PKIN
Market cap: US$200.5m
JRVR logo

James River Group Holdings

Symbol: NasdaqGS:JRVR
Market cap: US$182.6m
CIA logo

Citizens

Symbol: NYSE:CIA
Market cap: US$181.3m
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide